Benefits of GHK-Cu
[J]
For patients on weight management formulations (Wegovy, Saxenda, Zepbound), providers should follow FDA label guidance to monitor for suicidal thoughts or behaviors and discontinue medication if these occur
Tesamorelin and Visceral Fat Research Tesamorelin is a stabilized GHRH analog with an established clinical evidence base, including Phase III trial data supporting its use in HIV-associated lipodystrophy
doi: 10.3389/fmicb.2024.1446595 Received 10 June 2024 Accepted 02 August 2024 Published 14 August 2024 Volume 15 - 2024 Edited by Daniela De Biase, Sapienza University of Rome, Italy Reviewed by Wolfgang Buckel, University of Marburg, Germany Malte Sinn, University of Konstanz, Germany Updates Copyright 2024 Piskol, Lukat, Kaufhold, Heger, Blankenfeldt, Jahn and Moser